What are the recommended glucose control ranges for Fasting Blood Sugar (FBS) and Post-Prandial Blood Sugar (PPBS) in a patient with type 2 diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glucose Control Targets in Type 2 Diabetes Mellitus

For adults with type 2 diabetes, maintain fasting blood sugar (FBS) between 80-130 mg/dL and post-prandial blood sugar (PPBS) below 180 mg/dL, measured 1-2 hours after starting a meal. 1, 2

Fasting Blood Sugar (FBS) Targets

The recommended preprandial capillary plasma glucose target is 80-130 mg/dL for most nonpregnant adults with type 2 diabetes. 3, 1, 4

  • The lower limit was specifically raised from 70 mg/dL to 80 mg/dL to provide a safety margin and limit overtreatment in patients using glucose-lowering medications, particularly insulin 1, 4
  • Blood glucose below 70 mg/dL constitutes clinically important hypoglycemia requiring immediate treatment with 15-20g of fast-acting carbohydrate 1, 4
  • Blood glucose below 54 mg/dL represents Level 2 hypoglycemia where neuroglycopenic symptoms begin, indicating serious, clinically important hypoglycemia 1, 4

Post-Prandial Blood Sugar (PPBS) Targets

Peak postprandial capillary plasma glucose should remain below 180 mg/dL, measured 1-2 hours after beginning the meal. 3, 1, 2

  • This target has remained consistent across American Diabetes Association guidelines from 2004 through 2024, indicating strong consensus on its importance 3, 2
  • Postprandial measurements must be standardized at 1-2 hours after meal start to capture peak glucose levels accurately 1, 2
  • When A1C goals are not met despite achieving fasting glucose targets, postprandial glucose monitoring becomes critical to identify excessive postprandial excursions requiring specific intervention 1, 2, 5

Clinical Context and Rationale

Postprandial glucose control accounts for approximately 80% of HbA1c when HbA1c is below 6.2%, but only about 40% when HbA1c exceeds 9.0%. 6

  • Research demonstrates that 70% of patients with HbA1c below 7% still have postprandial glucose values exceeding 160 mg/dL after meals 7
  • Among type 2 diabetes patients treated with basal insulin who achieve adequate fasting glucose control (below 130 mg/dL), approximately 23.5% still fail to achieve HbA1c targets below 7% due to uncontrolled postprandial excursions 5
  • Control of fasting hyperglycemia alone is necessary but usually insufficient for achieving HbA1c goals below 7%; control of postprandial hyperglycemia is essential 6

Monitoring Frequency Based on Treatment Regimen

Patients on intensive insulin therapy should check glucose before meals and snacks, at bedtime, occasionally postprandially, and before/during/after exercise, typically requiring 6-10 checks daily. 1

  • For patients on single daily basal insulin injections, daily fasting blood glucose measurements are suggested as the fasting value best reflects the appropriateness of the basal insulin dose 3
  • More frequent monitoring is reasonable when glycemia is unstable, patients are prone to hypoglycemia, or treatment changes are made 1

Target Modification Based on Patient Characteristics

More stringent HbA1c targets (6.0-6.5%) may be considered in selected patients with short disease duration, long life expectancy, and no significant cardiovascular disease if achievable without significant hypoglycemia. 3

Less stringent HbA1c goals (7.5-8.0% or slightly higher) are appropriate for patients with:

  • History of severe hypoglycemia 3, 4
  • Limited life expectancy 3, 4
  • Advanced complications 3
  • Extensive comorbid conditions 3
  • Difficulty attaining targets despite intensive self-management education and multiple glucose-lowering agents including insulin 3

Critical Pitfalls to Avoid

Do not rely solely on fasting glucose or HbA1c to assess glycemic control, as postprandial excursions can be missed entirely. 1, 2

  • Ignoring postprandial glucose when A1C goals are not met despite good fasting values is a common error that leaves excessive postprandial excursions unaddressed 1, 2
  • Measuring postprandial glucose at inconsistent times should be avoided; standardize at 1-2 hours after meal start 1, 2
  • Setting fasting targets too low (below 80 mg/dL) increases hypoglycemia risk without clear benefit 1, 4
  • The coefficient of correlation between fasting plasma glucose and HbA1c is only 0.73, meaning fasting glucose alone poorly predicts overall glycemic control 7

References

Guideline

Blood Glucose Monitoring Targets for Adults with Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Postprandial Glucose Goals in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Target Blood Glucose Levels Before Meals for T2DM Patients on Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

International journal of clinical practice. Supplement, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.